The purpose of the present study was to investigate the efficacy of combined omega-3 and Korean red ginseng supplementation on ADHD symptoms and cognitive function in children with subthreshold ADHD.
Method:
120 children from 6 to 12 years with subthreshold ADHD were enrolled in this 12-week, double-blind, randomized, placebocontrolled study. The primary outcome was measured by Attention-Deficit Hyperactivity Disorder Rating Scale (ADHD-RS). Children Behavior Check List (CBCL), and neuropsychological tests assessing attention, memory, and executive function were included as secondary primary outcome measures.
Results:
Significant effects on the scores of ADHDRS, as well as several subscales of CBCL including ADHD and attention problem subscales were revealed.
Conclusion:
The combination of omega-3 and Korean red ginseng may have beneficial effects in children with subthreshold ADHD. Increased clinical awareness of ADHD symptoms even at a subthreshold level is needed.
AchenbachT. M.EdelbrockC. S. (1983). Manual for the child behavior checklist and revised child behavior profile. University of Vermont.
2.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing.
3.
ArterburnL. M.HallE. B.OkenH. (2006). Distribution, interconversion, and dose response of n−3 fatty acids in humans. The American Journal of Clinical Nutrition, 83(6), 1467S–1476S.
4.
BalázsJ.KeresztényÁ. (2014). Subthreshold attention deficit hyperactivity in children and adolescents: A systematic review. European Child & Adolescent Psychiatry, 23(6), 393–408.
5.
BiedermanJ.FitzgeraldM.KirovaA.-M.WoodworthK. Y.BiedermanI.FaraoneS. V. (2018). Further evidence of morbidity and dysfunction associated with subsyndromal ADHD in clinically referred children. The Journal of Clinical Psychiatry, 79(5): 17m11870.
6.
BlochM. H.QawasmiA. (2011). Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: Systematic review and meta-analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 50(10), 991–1000.
7.
BryanJ.OsendarpS.HughesD.CalvaresiE.BaghurstK.van KlinkenJ.-W. (2004). Nutrients for cognitive development in school-aged children. Nutrition Reviews, 62(8), 295–306.
8.
ChangJ. P.-C.JinglingL.HuangY.-T.LuY.-J.SuK.-P. (2016). Delay aversion, temporal processing, and N-3 fatty acids intake in children with attention-deficit/hyperactivity disorder (ADHD). Clinical Psychological Science, 4(6), 1094–1103.
9.
ChangJ. P.-C.SuK.-P.MondelliV.ParianteC. M. (2018). Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: A systematic review and meta-analysis of clinical trials and biological studies. Neuropsychopharmacology, 43(3), 534–545.
10.
ChoS.-C.KimH.-W.KimB.-N.ShinM.-S.YooH. J.KimJ.-W.BhangS. Y.ChoI. H. (2011). Are teacher ratings and parent ratings differently associated with children’s intelligence and cognitive performance?Psychiatry Investigation, 8(1), 15.
11.
ChoS.-Z.ChunS.-Y.HongK.-E.ShinM.-S. (2000). A study of the development and standardization of ADHD diagnostic system. Journal of the Korean Academy of Child and Adolescent Psychiatry, 11(1), 91–99.
12.
ChronisA. M.JonesH. A.RaggiV. L. (2006). Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. Clinical Psychology Review, 26(4), 486–502.
13.
CoghillD. R.BanaschewskiT.SoutulloC.CottinghamM. G.ZuddasA. (2017). Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder. European Child & Adolescent Psychiatry, 26(11), 1283–1307.
14.
CoghillD. R.RhodesS. M.MatthewsK. (2007). The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. Biological Psychiatry, 62(9), 954–962.
15.
CooperR. E.TyeC.KuntsiJ.VassosE.AshersonP. (2015). Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis. Journal of Psychopharmacology, 29(7), 753–763.
16.
CrippaA.AgostoniC.MauriM.MolteniM.NobileM. (2018). Polyunsaturated fatty acids are associated with behavior but not with cognition in children with and without ADHD: An Italian study. Journal of Attention Disorders, 22(10), 971–983.
17.
DöpfnerM.DoseC.BreuerD.HeintzS.SchiffhauerS.BanaschewskiT. (2019). Efficacy of omega-3/omega-6 fatty acids in preschool children at risk of ADHD: A randomized placebo-controlled trial. Journal of Attention Disorders. https://doi.org/10.1177/1087054719883023
18.
FavaM.EvinsA. E.DorerD. J.SchoenfeldD. A. (2003). The problem of the placebo response in clinical trials for psychiatric disorders: Culprits, possible remedies, and a novel study design approach. Psychotherapy and Psychosomatics, 72(3), 115–127.
19.
GengJ.DongJ.NiH.LeeM. S.WuT.JiangK.WangG.ZhouA. L.MaloufR. (2010). Ginseng for cognition. Cochrane Database of Systematic Reviews, 12, CD007769.
20.
GilliesD.SinnJ. K.LadS. S.LeachM. J.RossM. J. (2012). Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database of Systematic Review, 7: 11-12.
21.
GoodeA. P.CoeytauxR. R.MaslowG. R.DavisN.HillS.NamdariB.LaPointeN. M.BefusD.LallingerK. R.BowenS. E. (2018). Nonpharmacologic treatments for attention-deficit/hyperactivity disorder: A systematic review. Pediatrics, 141(6), e20180094.
22.
HarpinV.MazzoneL.RaynaudJ.KahleJ.HodgkinsP. (2016). Long-term outcomes of ADHD: A systematic review of self-esteem and social function. Journal of Attention Disorders, 20(4), 295–305.
23.
HeoJ. H.LeeS. T.ChuK.OhM.ParkH. J.ShimJ. Y.KimM. (2008). An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer’s disease. European Journal of Neurology, 15(8), 865–868.
24.
ItohT.ZangY. F.MuraiS.SaitoH. (1989). Effects of Panax ginseng root on the vertical and horizontal motor activities and on brain monoamine-related substances in mice. Planta Medica, 55(5), 429–433.
25.
JinY.CuiR.ZhaoL.FanJ.LiB. (2019). Mechanisms of Panax ginseng action as an antidepressant. Cell Proliferation, 52(6), e12696.
26.
KimH. (2001). Assessment of memory disorders using Rey-Kim memory test. The Korean Journal of Rehabilitation Psychology, 8, 29–48.
KimH. J.KimP.ShinC. Y. (2013). A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system. Journal of Ginseng Research, 37(1), 8.
29.
KimH.-W.ChoS.-C.KimB.-N.KimJ.-W.ShinM.-S.KimY. (2009). Perinatal and familial risk factors are associated with full syndrome and subthreshold attention-deficit hyperactivity disorder in a Korean community sample. Psychiatry Investigation, 6(4), 278.
30.
KimY. S.CheonK. A.KimB. N.ChangS. A.YooH. J.KimJ. W.ChoS. C.SeoD. H.BaeM. O.SoY. K.NohJ. S. (2004). The reliability and validity of kiddie-schedule for affective disorders and schizophrenia-present and lifetime version-Korean version (K-SADS-PL-K). Yonsei Medical Journal, 45(1), 81–89.
31.
KirovaA.-M.KelbermanC.StorchB.DiSalvoM.WoodworthK. Y.FaraoneS. V.BiedermanJ. (2019). Are subsyndromal manifestations of attention deficit hyperactivity disorder morbid in children? A systematic qualitative review of the literature with meta-analysis. Psychiatry Research, 274, 75–90.
32.
KoH.-J.KimI.KimJ.-B.MoonY.WhangM.-C.LeeK.-M.JungS.-P. (2014). Effects of Korean red ginseng extract on behavior in children with symptoms of inattention and hyperactivity/impulsivity: A double-blind randomized placebo-controlled trial. Journal of Child and Adolescent Psychopharmacology, 24(9), 501–508.
33.
KooH.-J.ShinM.-S. (2008). A standardization study of children’s color trails test (CCTT). Journal of the Korean Academy of Child and Adolescent Psychiatry, 19(1), 28–37.
34.
LeeJ.LeeA.KimJ.-H.ShinY. M.KimS.-J.ChoW. D.LeeS. I. (2020). Effect of omega-3 and Korean red ginseng on children with attention deficit hyperactivity disorder: An open-label pilot study. Clinical Psychopharmacology and Neuroscience, 18(1), 75.
35.
LeeS. H.ParkW. S.LimM. H. (2011). Clinical effects of Korean red ginseng on attention deficit hyperactivity disorder in children: An observational study. Journal of Ginseng Research, 35(2), 226.
36.
LinP.-Y.HuangS.-Y.SuK.-P. (2010). A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biological Psychiatry, 68(2), 140–147.
37.
LiuL.Hoang-GiaT.WuH.LeeM.-R.GuL.WangC.YunB. S.WangQ.YeS.SungC.-K. (2011). Ginsenoside Rb1 improves spatial learning and memory by regulation of cell genesis in the hippocampal subregions of rats. Brain Research, 1382, 147–154.
38.
MalmbergK.EdbomT.WargeliusH. L.LarssonJ. O. (2011). Psychiatric problems associated with subthreshold ADHD and disruptive behaviour diagnoses in teenagers. Acta Paediatrica, 100(11), 1468–1475.
39.
MarcusD. K.BarryT. D. (2011). Does attention-deficit/hyperactivity disorder have a dimensional latent structure? A taxometric analysis. Journal of Abnormal Psychology, 120(2), 427.
40.
McNamaraR. K.CarlsonS. E. (2006). Role of omega-3 fatty acids in brain development and function: Potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins, Leukotrienes and Essential Fatty Acids, 75(4–5), 329–349.
41.
MichelsonD.FariesD.WernickeJ.KelseyD.KendrickK.SalleeF. R.SpencerT.; Atomoxetine ADHD Study Group. (2001). Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study. Pediatrics, 108(5), e83–e83.
42.
MilteC. M.SinnN.BuckleyJ. D.CoatesA. M.YoungR. M.HoweP. R. (2011). Polyunsaturated fatty acids, cognition and literacy in children with ADHD with and without learning difficulties. Journal of Child Health Care, 15(4), 299–311.
43.
MontgomeryP.BurtonJ. R.SewellR. P.SpreckelsenT. F.RichardsonA. J. (2013). Low blood long chain omega-3 fatty acids in UK children are associated with poor cognitive performance and behavior: A cross-sectional analysis from the DOLAB study. PLoS One, 8(6), e66697.
44.
NiederhoferH. (2009). Panax ginsengmayimprove some symptoms of attention-deficit hyperactivity disorder. Journal of Dietary Supplements, 6(1), 22–27.
45.
NormanG. R.SloanJ. A.WyrwichK. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41(5), 582–592.
46.
ParkK.-C.JinH.ZhengR.KimS.LeeS.-E.KimB.-H.YimS.-V. (2019). Cognition enhancing effect of panax ginseng in Korean volunteers with mild cognitive impairment: A randomized, double-blind, placebo-controlled clinical trial. Translational and Clinical Pharmacology, 27(3), 92–97.
47.
RapaportM. H.NierenbergA. A.HowlandR.DordingC.SchettlerP. J.MischoulonD. (2011). The treatment of minor depression with St. John’s Wort or citalopram: Failure to show benefit over placebo. Journal of Psychiatric Research, 45(7), 931–941.
48.
ScharfenJ.PetersJ. M.HollingH. (2018). Retest effects in cognitive ability tests: A meta-analysis. Intelligence, 67, 44–66.
49.
SchiavoneN.VirtaM.LeppämäkiS.LaunesJ.VanninenR.Tuulio-HenrikssonA.ImmonenS.JärvinenI.LehtoE.MichelssonK.HokkanenL. (2019). ADHD and subthreshold symptoms in childhood and life outcomes at 40 years in a prospective birth-risk cohort. Psychiatry Research, 281, 112574.
50.
ShankmanS. A.LewinsohnP. M.KleinD. N.SmallJ. W.SeeleyJ. R.AltmanS. E. (2009). Subthreshold conditions as precursors for full syndrome disorders: A 15-year longitudinal study of multiple diagnostic classes. Journal of Child Psychology and Psychiatry, 50(12), 1485–1494.
51.
SmithI.WilliamsonE. M.PutnamS.FarrimondJ.WhalleyB. J. (2014). Effects and mechanisms of ginseng and ginsenosides on cognition. Nutrition Reviews, 72(5), 319–333.
52.
SoY. K.NohJ. S.KimY. S.KoS. G.KohY. J. (2002). The reliability and validity of Korean parent and teacher ADHD rating scale. Journal of Korean Neuropsychiatric Association, 41(2), 283–289.
53.
Sonuga-BarkeE. J.BrandeisD.CorteseS.DaleyD.FerrinM.HoltmannM.StevensonJ.DanckaertsM.Van der OordS.DöpfnerM.DittmannR. W. (2013). Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. American Journal of Psychiatry, 170(3), 275–289.
54.
TachikawaE.KudoK. (2004). Proof of the mysterious efficacy of ginseng: Basic and clinical trials: Suppression of adrenal medullary function in vitro by ginseng. Journal of Pharmacological Sciences, 95(2), 140–144.
